Advertisement

Etiologic Concepts of Inflammatory Bowel Diseases: Past, Present, and Future

  • Joseph B. Kirsner

Abstract

Ulcerative colitis and Crohn’s disease represent a group of inflammatory and ulcerative disorders of the large and small intestine of unknown etiology and pathogenesis (1). They occur chiefly in developed countries (United States, Europe), affecting people of all ages, males and females approximately equally, and principally younger individuals. The common symptoms of ulcerative colitis are early constipation, rectal bleeding and urgency, abdominal discomfort, diarrhea, and weight loss. Laboratory data include iron deficiency anemia, lowered serum proteins, and the absence of conventional bacterial pathogens in the stool. The typical clinical manifestations of Crohn’s disease are cramping lower abdominal pain, diarrhea, fever, anorexia, and weight loss. The laboratory data include normal or elevated leukocyte counts; increased erythrocyte sedimentation rate; iron, B12, or folate deficiency; lowered serum proteins; and other indications of undernutrition. Their course is acute and chronic with remissions and exacerbations, intestinal and systemic complications, and variable responses to medical and surgical treatment.

Keywords

Ulcerative Colitis Chronic Ulcerative Colitis Tive Colitis Tory Bowel Disease Cerative Colitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kirsner JB, Shorter RG. Inflammatory Bowel Disease. 4th ed. Baltimore, MD: Williams & Wilkins, 1995.Google Scholar
  2. 2.
    Kirsner JB. The historical basis of the idiopathic inflammatory bowel diseases. J Inflamm Bowel Diseases 1995;1:2–26.Google Scholar
  3. 3.
    Morson BC. Current concepts of colitis. The 1970 Lettsomian Lectures, Trans Med Soc, London, 1970;86:159–176.Google Scholar
  4. 4.
    Wilks S. Morbid appearances in the intestine of Miss Bankes. London Medical Gazette 1859;2:264–265.Google Scholar
  5. 5.
    Wilks S., Moxon W. Lectures on Pathological Anatomy. London 2nd ed. 1875;408.Google Scholar
  6. 6.
    Hurst AF. Ulcerative colitis. Guy’s Hosp Rep 1921;71:26–41.Google Scholar
  7. 7.
    Bargen JA. Experimental studies on the etiology of chronic ulcerative colitis (Preliminary Report). JAMA 1924;83:332–336.CrossRefGoogle Scholar
  8. 8.
    Bargen JA, Jackman RJ, Kerr JG. Studies on the life histories of patients with chronic ulcerative colitis (thrombo ulcerative colitis) with some suggestions for treatment. Ann Int Med 1938;12:339–352.Google Scholar
  9. 9.
    Kirsner JB, Goldgraber MB. Hypersensitivity, autoimmunity and the digestive tract. Gastroenterology 1960;38:536–562.PubMedGoogle Scholar
  10. 10.
    Fabry W. Cited by: Fielding JF. Crohn’s disease and Dalziel’s syndrome. J Clin Gastroenterol 1988;10:279–285.CrossRefGoogle Scholar
  11. 11.
    Morgagni GB. The seats and causes of disease investigated by anatomy. Five books containing a great variety of dissections with remarks (Translated from the Latin of John Baptist Morgagni by Benjamin Alexander.) 3 Vol. London: Millar A., Cadell T., 1769.Google Scholar
  12. 12.
    Dalziel TK. Chronic interstitial enteritis. Br Med J (Clin Res) 1913;2:1068–1070.Google Scholar
  13. 13.
    Coffen TH. Nonspecific granuloma of the intestine causing intestinal obstruction. JAMA 1925;35:1303–1304.Google Scholar
  14. 14.
    Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis: a pathologic and clinical entity. JAMA 1932;99:1323–1329.CrossRefGoogle Scholar
  15. 15.
    Lockhart-Mummery HE, Morson BC. Crohn’s disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis. Gut 1960;1:87–105.PubMedCrossRefGoogle Scholar
  16. 16.
    Warren S, Sommers SC. Cicatrizing enteritis (regional ileitis) as a pathologic entity: analysis of 120 cases. Am J Pathol 1948;24:475–501.PubMedGoogle Scholar
  17. 17.
    Reichert FL, Mathes ME. Experimental lymphoderma of the intestinal tract and its relation to regional cicatrizing enteritis. Ann Surg 1936;104:601–614.PubMedCrossRefGoogle Scholar
  18. 18.
    Melrose AG. The geographic incidence of chronic ulcerative colitis in Britain. Gastroenterology 1955;29:1055–1060.PubMedGoogle Scholar
  19. 19.
    Acheson ED. The distribution of ulcerative colitis and regional enteritis in United States veterans with particular reference to the Jewish religion. Gut 1960;1:291–293.PubMedCrossRefGoogle Scholar
  20. 20.
    Monk M, Mendeloff AI, Siegel CI, et al. An epidemiologic study of ulcerative colitis and regional enteritis among adults in Baltimore. I. Hospital incidence and prevalence 1960–1963. Gastroenterology 1967;53:198–210.Google Scholar
  21. 21.
    Mendeloff AI. The epidemiology of idiopathic inflammatory bowel disease. In: Kirnser JB, Shorter RG, eds. Inflammatory Bowel Disease, Philadelphia: Lea & Febiger, 1975;3–19.Google Scholar
  22. 22.
    Mendeloff AI. The epidemiology of inflammatory bowel disease. Clin Gastroenterol 1980;9:259–270.PubMedGoogle Scholar
  23. 23.
    Samuelsson SM. Ulceros colit och proktit. Thesis, University of Upsala 1976;1-182.Google Scholar
  24. 24.
    Harries AD, Baird A, Rhodes J. Nonsmoking: a feature of ulcerative colitis. Brit Med J 1982;284:706.CrossRefGoogle Scholar
  25. 25.
    Kessler H, Diamond KI. Epidemiological studies of Parkinson’s disease. I. Smoking and Parkinson’s Disease. Am J Epidemiol 1971;94:16–25.PubMedGoogle Scholar
  26. 26.
    Calkins BM. Inflammatory bowel disease. In Digestive Diseases in the United States—Epidemiology and Impact. Everhart JK, National Digestive Disease Working Group. U. S. Department Health and Human Services. National Institutes of Health, Bethesda, MD 1994;509–550.Google Scholar
  27. 27.
    Pavlov I. Conditioned Reflexes (Anrep GV, trans.), New York: Oxford, 1927.Google Scholar
  28. 28.
    Cannon WB. Bodily Changes in Pain, Hunger, Fear and Rage. 2nd ed., New York: Appleton, 1929.Google Scholar
  29. 29.
    Grace WJ, Wolf S, Wolff HG. The Human Colon, New York: Hoeker, PB; 1951;225–227.Google Scholar
  30. 30.
    Almy TP, Tulin M. Alterations in colonic function in man under stress. I. Experimental production of changes simulating the irritable colon. Gastroen-terology 1947;8:616–626.Google Scholar
  31. 31.
    Murray CD. Psychogenic factors in the etiology of ulcerative colitis. Am J Dig Dis 1930;180:239–248.Google Scholar
  32. 32.
    Sullivan AJ, Chandler CA. Ulcerative colitis of psychogenic origin: report of six cases. Yale J Biol Med 1932;4:779–786.PubMedGoogle Scholar
  33. 33.
    White BV. Effect of ileostomy and colectomy on personality adjustment of patients with ulcerative colitis. New Engl J Med 1951;244:537–540.PubMedCrossRefGoogle Scholar
  34. 34.
    Karush A, Daniels GE, Flood C, et al. Psychotherapy in chronic ulcerative colitis. Philadelphia: W.B. Saunders, 1977.Google Scholar
  35. 35.
    North CS, Clouse RE, Spitznagel EL, et al. The relation of ulcerative colitis to psychiatric factors: a review of findings and methods. Am J Psychiatry 1990;147:974–981.PubMedGoogle Scholar
  36. 36.
    Heizer JE, Chammas S, Norland CC, et al. A study of the association between Crohn’s disease and psychiatric illness. Gastroenterology 1984;86:324–330.Google Scholar
  37. 37.
    Sternberg EM, Chrousos GP, Wilder RL, et al. The stress response and the regulation of inflammatory disease. Ann Int Med 1992;117:854–866.PubMedGoogle Scholar
  38. 38.
    Kirsner JB. The Development of American Gastroenterology. New York: Raven Press, 1990.Google Scholar
  39. 39.
    Peterson EA, Mandel RM. Infectious diseases—old diseases return and new agents emerge (editorial). Arch Int Med 1995;155:1571–1572.CrossRefGoogle Scholar
  40. 40.
    Wensinck F. Cited by: Van de Merwe JP. A possible role of Eubacterium and Peptostreptococcus species in the aetiology of Crohn’s disease. In Pena AS, Weterman IT, Booth CC, Strober W, eds. Recent Advances in Crohn’s Disease. The Hague: Martinus Nijhoff 1981;201–206.Google Scholar
  41. 41.
    Ekbom J, Wakefield AJ, Zack M, et al. Perinatal measles infection and subsequent Crohn’s disease. Lancet 1994;344:508–510.PubMedCrossRefGoogle Scholar
  42. 42.
    Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn’s disease. Gastroenterol Clin of North Am 1995:24:475–507.Google Scholar
  43. 43.
    Andresen AFR. Ulcerative colitis—an allergic phenomenon. Am J Dig Dis 1942;9:91–98.CrossRefGoogle Scholar
  44. 44.
    Rowe AH. Chronic ulcerative colitis: allergy in its etiology. Ann Int Med 1942;17:83–100.Google Scholar
  45. 45.
    Walzer M, Gray I, Straus HW, et al. Studies in experimental hypersensitiveness in the rhesus monkey: allergic reaction in passively locally sensitized abdominal organs. J Immunol 1938;34:91–95.Google Scholar
  46. 46.
    Kirsner JB, Shorter RG. Recent developments in “nonspecific” inflammatory bowel disease. New Engl J Med 1982;306:775–785, 837-848.PubMedCrossRefGoogle Scholar
  47. 47.
    Besredka A. La vaccination contre les etats typhoides par la voie Buccale. Ann Inst Pasteur 1919;33:882–903.Google Scholar
  48. 48.
    Davies A. An investigation into the serological properties of dysentery stools. Lancet 1922;2:1009–1012.CrossRefGoogle Scholar
  49. 49.
    Kirsner JB, Palmer WL. Ulcerative colitis (considerations of its etiology and treatment). JAMA 1954;155:341–346.Google Scholar
  50. 50.
    Goldgraber MB, Kirsner JB. The arthus phenomenon in the colon of rabbits. AMA Arch Path 1959;67:556–571.Google Scholar
  51. 51.
    Kirsner JB, Elchlepp J. The production of an experimental colitis in rabbits. Trans Assoc American Physicians 1957;70:102–119.Google Scholar
  52. 52.
    Auer J. Local autoinoculation of the sensitized organism with foreign protein as a cause of abnormal reactions. J Exper Med 1920;32:427–444.CrossRefGoogle Scholar
  53. 53.
    Heremans JF. Les Globulines Seriques du Systeme Gamma, leur Nature et leur Pathologic Brussels: Arcia 1960.Google Scholar
  54. 54.
    Tomasi TB, Tan EM, Solomon A, et al. Characteristics of an immune system common to certain external secretions. J Exp Med 1965;121:101–124.PubMedCrossRefGoogle Scholar
  55. 55.
    Bienenstock J. The physiology of the local immune response. In: Immunology of the Gastrointestinal Tract. Asquith P, ed. London: Churchill Livingstone 1979.Google Scholar
  56. 56.
    Kirsner JB. Inflammatory bowel disease—overview of etiology and pathogenesis. In: Berk JE, ed. Bockus Gastroenterology. Philadelphia: W.B. Saunders 1985.Google Scholar
  57. 57.
    Shorter RG, Huizenga KA, Spencer RJ. A working hypothesis for the etiology and pathogenesis of nonspecific inflammatory bowel disease. Digest Dis Sci 1972;17:1024–1032.CrossRefGoogle Scholar
  58. 58.
    Elson CO. The Immunology of Inflammatory Bowel Disease. In: Inflammatory Bowel Disease. 4th ed. Kirsner JB, Shorter RG, eds. Baltimore: Williams & Wilkins, 1994.Google Scholar
  59. 59.
    Weiner HL. Oral tolerance: mobilizing the gut. Hospital Practice (Sept) 1995;15:53–58.Google Scholar
  60. 60.
    Yang P, Jarnerot G, Danielsson D, et al. P-ANCA in monozygotic twins with inflammatory bowel disease. Gut 1995;36:887–890.PubMedCrossRefGoogle Scholar
  61. 61.
    Hertervig E, Wieslander J, Johansson C, et al. Antineutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Scand J Gastroenterol 1995;30:693–698.PubMedCrossRefGoogle Scholar
  62. 62.
    Castro G. Immunological regulation of epithelial function. Am J Physiol 1982;243 (Gastrointestinal Liver Physiol. 6):G321–G329.PubMedGoogle Scholar
  63. 63.
    Pulverer G, Ko HL, Berth J. Immunomodulating effect of antibiotics on intestinal microflora. Path Biol 1993;41:753–758.Google Scholar
  64. 64.
    Metchnikoff E. Untersuchungen uber die intracellularle Verdauung bei wirbellosen thieren. Arbeit Zool Inst Univ Wien 1883;5:141–168. (See also Metschnikoff O. Life of Elie Metschnikoff. New York: Houghton Mifflin Co. 1921).Google Scholar
  65. 65.
    Ehrlich P. Experimental researches on specific therapy: on immunity with special reference to the relationship between distribution and action of antigens. In: Himmelwert F, ed. Collected Papers. Vol. 3. New York: Pergamon Press, 1960 (Originally Published 1908).Google Scholar
  66. 66.
    Menkin V. Studies on inflammation; mechanisms of fixation by inflammatory reaction. J Exper Med 1931;53:171–177.CrossRefGoogle Scholar
  67. 67.
    McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969;244:6049–6055.PubMedGoogle Scholar
  68. 68.
    Babior BM, Kipnes RS, Curnutte JT. Biological defense mechanisms, the production by leukocytes of Superoxide—a potential bactericidal agent. J Clin Invest 1973;52:741–744.PubMedCrossRefGoogle Scholar
  69. 69.
    Granger DN, Rutili G, McCord JM. Superoxide radicals in feline intestinal ischemia. Gastroenterology 1981;81:22–29.PubMedGoogle Scholar
  70. 70.
    Grisham MB, Granger DN. Neutrophil mediated mucosal injury—role of reactive oxygen metabolites. Dig Dis Sci 1988;33:6S–15S.PubMedCrossRefGoogle Scholar
  71. 71.
    Gery I, Gersham RK, Waksman BH. Potentiates of the T-lymphocyte response to mitogens. I. The responding cell. J Exp Med 1972;136:128–142.PubMedCrossRefGoogle Scholar
  72. 72.
    Paetkau V, Mills G, Gerhart S, et al. Proliferation of murine thymic lymphocytes in vitro is mediated by the concanavalin-α-induced release of a lymphokine (Costimulator). J Immunol 1976;117:1320–1324.PubMedGoogle Scholar
  73. 73.
    Chen DM, di Sabato G. Further studies on the thymocyte stimulating factor. Cell Immunol 1976;22:211–224.PubMedCrossRefGoogle Scholar
  74. 74.
    Sharon P, Stenson WK. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 1984;86:453–460.PubMedGoogle Scholar
  75. 75.
    Fiocchi C. Production of inflammatory cytokines in the intestinal lamina propria. Immunol Res 1991;10:239–246.PubMedCrossRefGoogle Scholar
  76. 76.
    Podolsky DK. Inflammatory bowel disease. New Engl J Med 1991;325:928–937, 1008-1016.PubMedCrossRefGoogle Scholar
  77. 77.
    Sartor RB. Cytokines in intestinal inflammation. Pathophysiological and clinical considerations. Gastroenterology 1994;106:533–539.PubMedGoogle Scholar
  78. 78.
    Almy TP, Sherlock P. Genetic aspects of ulcerative colitis and regional enteritis. Gastroenterology 1966;51:757–760.PubMedGoogle Scholar
  79. 79.
    Kirsner JB, Spencer JA. Family occurrences of ulcerative colitis, regional enteritis, and ileocolitis. Ann Int Med 1963;59:133–144.PubMedGoogle Scholar
  80. 80.
    McConnell RB. The genetics of gastrointestinal disorders. London: Oxford University Press, 1966;128–142. Cited in: Genetics of gastrointestinal disorders. Clin Gastroenterol 1973;2:489-724.Google Scholar
  81. 81.
    Moltke O. Familial occurrence of non-specific ulcerative colitis. Acta Med Scand 1936;78(suppl 72): 426–432.Google Scholar
  82. 82.
    Schlesinger B, Platt J. Ulcerative colitis in childhood and a follow-up study. Proc Royal Soc Med 1958;51:733–735.Google Scholar
  83. 83.
    Morris PJ. Familial ulcerative colitis. Gut 1965;6:176–178.PubMedCrossRefGoogle Scholar
  84. 84.
    Thayer WR, Jr. Crohn’s disease (regional enteritis). Scand J Gastroenterol 1970;6:165–185.Google Scholar
  85. 85.
    Kuspira J, Bhambhani R, Singh SM, et al. Familial occurrences of Crohn’s disease. Human Heredity 1972;22:239–242.PubMedCrossRefGoogle Scholar
  86. 86.
    Kirsner JB. Genetic aspects of inflammatory bowel disease. Clin Gastroenterol 1973;2:557–576.Google Scholar
  87. 87.
    Purrmann J, Bertrams J, Borchard F, et al. Monozygotic triplets with Crohn’s disease of the colon. Gastroenterology 1986;91:1553–1559.PubMedGoogle Scholar
  88. 88.
    Singer HC, Anderson JGD, Frischer H, et al. Familial aspects of inflammatory bowel disease. Gastroenterology 1971;61:423–430.PubMedGoogle Scholar
  89. 89.
    Kirsner JB. Inflammatory Bowel Disease. Part I. Nature and Pathogenesis. II. Clinical and Therapeutic Aspects. Disease-A-Month (Masters in Medicine) 1991;37:(10):610–666, 673-746.CrossRefGoogle Scholar
  90. 90.
    Monsen U, Iselius L, Johansson C, et al. Evidence for a major additive gene in ulcerative colitis. Clin Gen 1989;36:411–414.Google Scholar
  91. 91.
    Kuster W, Pascoe L, Purrmann J, et al. The genetics of Crohn’s disease—complex segregation analysis of a family study with 265 patients with Crohn’s disease. Am J Med Gen 1989;32:105–108.CrossRefGoogle Scholar
  92. 92.
    Yang H, Rotter JI. Genetics of inflammatory bowel disease. In Targan SR, Shanahan K, eds. Inflammatory Bowel Disease (From Bench to Bedside). Baltimore: Williams & Wilkins, 1994.Google Scholar
  93. 93.
    Elson CO, Sartor RB, Tennyson GS, et al. Experimental models of inflammatory bowel disease. Gastroenterology 1995;109:1344–1367.PubMedCrossRefGoogle Scholar
  94. 94.
    Nepom GT. Class II antigens and disease susceptibility. Ann Rev Med 1995;46:117–125.Google Scholar
  95. 95.
    Binder V, Park H, Hansen PK. et al. Incidence and prevalence of ulcerative colitis and Crohn’s disease in the county of Copenhagen—1962 to 1978. Gastroenterology 1982;83:563–568.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Joseph B. Kirsner

There are no affiliations available

Personalised recommendations